WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma

Glioblastoma (GBM) is a universally fatal brain cancer, for which novel therapies targeting specific underlying oncogenic events are urgently needed. While the WNT pathway has been shown to be frequently activated in GBM, constituting a potential therapeutic target, the relevance of WNT6, an activat...

Full description

Bibliographic Details
Main Author: Gonçalves, Céline S. (author)
Other Authors: Castro, Joana Isabel Martins Cosme Vieira (author), Pojo, Marta (author), Martins, Eduarda P. (author), Queirós, Sandro Filipe Monteiro (author), Chautard, Emmanuel (author), Taipa, Ricardo (author), Pires, Manuel Melo (author), Pinto, Afonso A. (author), Pardal, Fernando (author), Custódia, Carlos (author), Faria, Cláudia C. (author), Clara, Carlos (author), Reis, R. M. (author), Sousa, Nuno (author), Costa, Bruno Marques (author)
Format: article
Language:eng
Published: 2018
Subjects:
biomarker
glioblastoma
oncogene
prognosis
WNT6
WNT pathway
Ciências Médicas::Medicina Básica
Science & Technology
Online Access:http://hdl.handle.net/1822/57857
Country:Portugal
Oai:oai:repositorium.sdum.uminho.pt:1822/57857

Internet

http://hdl.handle.net/1822/57857

Similar Items